chr2-178794954-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6
The NM_001267550.2(TTN):c.1213G>A(p.Ala405Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000866 in 1,604,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.1213G>A | p.Ala405Thr | missense_variant | 7/363 | ENST00000589042.5 | NP_001254479.2 | |
TTN | NM_133379.5 | c.1213G>A | p.Ala405Thr | missense_variant | 7/46 | ENST00000360870.10 | NP_596870.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.1213G>A | p.Ala405Thr | missense_variant | 7/363 | 5 | NM_001267550.2 | ENSP00000467141.1 | ||
TTN | ENST00000360870.10 | c.1213G>A | p.Ala405Thr | missense_variant | 7/46 | 5 | NM_133379.5 | ENSP00000354117.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000398 AC: 97AN: 243686Hom.: 1 AF XY: 0.000370 AC XY: 49AN XY: 132316
GnomAD4 exome AF: 0.0000826 AC: 120AN: 1451962Hom.: 0 Cov.: 32 AF XY: 0.0000830 AC XY: 60AN XY: 722706
GnomAD4 genome AF: 0.000125 AC: 19AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 26, 2014 | Variant classified as Uncertain Significance - Favor Benign. The Ala405Thr varia nt in TTN has not been previously reported in individuals with cardiomyopathy. I t has also been identified in 1/10 Southern African chromosomes in the Bushman p opulation (dbSNP rs112266780). Computational prediction tools and conservation a nalysis suggest that this variant may not impact the protein (several mammals ca rry the variant amino acid), though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the Ala4 05Thr variant is uncertain, these data suggest that it is more likely to be beni gn. - |
TTN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2020 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at